The effects of JWB1-84-1 on memory-related task performance by amyloid Aβ transgenic mice and by young and aged monkeys

Neuropharmacology

Volumn 53, Issue 5, 2007, Pages 588-600

  Sood, Ajay ^a   Warren Beach, J ^c   Webster, Scott J ^a   Terry, Alvin V ^a   Buccafusco, Jerry J ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Alzheimer's disease; Attention deficit; Cognition; Delayed matching; Drug development; Spatial memory

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINE; JWB1 84 1; PIPERAZINE DERIVATIVE; SODIUM CHLORIDE; TERTIARY AMINE; UNCLASSIFIED DRUG;

ACCURACY; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; ATTENTION DISTURBANCE; CELL PROTECTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; FEMALE; MALE; MAZE TEST; MONKEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYMPTOMATOLOGY; TASK PERFORMANCE; TRANSGENIC MOUSE; WILD TYPE; WORKING MEMORY;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; ANXIETY; BRAIN CHEMISTRY; DARKNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HAND STRENGTH; LIGHT; MACACA MULATTA; MACACA NEMESTRINA; MALE; MAZE LEARNING; MEMORY; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUSCULOSKELETAL EQUILIBRIUM; NEUROPROTECTIVE AGENTS; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; PYRIDINES;

EID: 34848914887     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.06.028     Document Type: Article

References (45)

1. Adamczyk A., Jesko H., and Strosznajder R.P. Alzheimer's disease related peptides affected cholinergic receptor mediated poly(ADP-ribose) polymerase activity in the hippocampus. Folia Neuropathol. 43 (2005) 139-142
2. Alkondon M., Pereira E.F., Cortes W.S., Maelicke A., and Albuquerque E.X. Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur. J. Neurosci. 9 (1997) 2734-2742
3. Arendash G.W., King D.L., Gordon M.N., Morgan D., Hatcher J.M., Hope C.E., and Diamond D.M. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891 (2001) 42-53
4. Borchelt D.R., Ratovitski T., van Lare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., and Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19 (1997) 939-945
5. Briggs C.A., Anderson D.J., Brioni J.D., Buccafusco J.J., Buckley M.J., Campbell J.E., Decker M.W., Donnelly-Roberts D., Elliott R.L., Gopalakrishnan M., Holladay M.W., Hui Y.H., Jackson W.J., Kim D.J., Marsh K.C., O'Neill A., Prendergast M.A., Ryther K.B., Sullivan J.P., and Arneric S.P. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol. Biochem. Behav. 57 (1997) 231-241
6. Buccafusco J.J. Neuronal nicotinic receptor subtypes: defining therapeutic targets. Mol. Interv. 4 (2004) 285-295
7. Buccafusco J.J., and Jackson W.J. Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol. Aging 12 (1991) 233-238
8. Buccafusco J.J., and Terry Jr. A.V. Multiple central nervous system targets for eliciting beneficial effects on memory and cognition. J. Pharmacol. Exp. Ther. 295 (2000) 438-446
9. Buccafusco J.J., Jackson W.J., Terry Jr. A.V., Marsh K.C., Decker M.W., and Arneric S.P. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Psychopharmacology (Ber.). 120 (1995) 256-266
10. Buccafusco J.J., Terry Jr. A.V., and Murdoch P.B. A computer-assisted cognitive test battery for aged monkeys. J. Mol. Neurosci. 19 (2002) 179-185
11. Buccafusco J.J., Jackson W.J., Stone J.D., and Terry A.V. Sex dimorphisms in the cognitive-enhancing action of the Alzheimer's drug donepezil in aged Rhesus monkeys. Neuropharmacology 44 (2003) 381-389
12. Buccafusco J.J., Terry Jr. A.V., Goren T., and Blaugrun E. Potential cognitive actions of (n-propargly-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (TV3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task. Neuroscience 119 (2003) 669-678
13. Buccafusco, J.J., Beach, W.B., Terry, A.V., Jr., Jonnala, R.R., 2005a. Analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders. Patent Number: 6,881,738; issue date: 04/19/05.
14. Buccafusco J.J., Letchworth S.R., Bencherif M., and Lippiello P.M. Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends Pharmacol. Sci. 26 (2005) 352-360
15. Chen G., Chen K.S., Kobayashi D., Barbour R., Motter R., Games D., Martin S.J., and Morris R.G. Active beta-amyloid immunization restores spatial learning in PDAPP mice displaying very low levels of beta-amyloid. J. Neurosci. 27 (2007) 2654-2662
16. Christensen H., Kopelman M.D., Stanhope N., Lorentz L., and Owen P. Rates of forgetting in Alzheimer dementia. Neuropsychologia 36 (1998) 547-557
17. Elrod K., Buccafusco J.J., and Jackson W.J. Nicotine enhances delayed matching-to-sample performance by primates. Life Sci. 43 (1988) 277-287
18. Gallagher M., and Rapp P.R. The use of animal models to study the effects of aging on cognition. Annu. Rev. Psychol. 48 (1997) 339-370
19. Goto Y., Niidome T., Akaike A., Kihara T., and Sugimoto H. Amyloid beta-peptide preconditioning reduces glutamate-induced neurotoxicity by promoting endocytosis of NMDA receptor. Biochem. Biophys. Res. Commun. 351 (2006) 259-265
20. Hyde L.A., Hoplight B.J., and Denenberg V.H. Water version of the radial-arm maze: learning in three inbred strains of mice. Brain Res. 785 (1998) 236-244
21. Jankowsky J.L., Slunt H.H., Gonzales V., Jenkins N.A., Copeland N.G., and Borchelt D.R. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol. Aging 25 (2004) 885-892
22. Jones I.W., Westmacott A., Chan E., Jones R.W., Dineley K., O'Neill M.J., and Wonnacott S. Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes. J. Mol. Neurosci. 30 (2006) 83-84
23. Jonnala R.R., and Buccafusco J.J. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J. Neurosci. Res. 66 (2001) 565-572
24. Levin E.D. Nicotinic receptor subtypes and cognitive function. J. Neurobiol. 53 (2002) 633-640
25. Li X.D., and Buccafusco J.J. Effect of beta-amyloid peptide 1-42 on the cytoprotective action mediated by alpha7 nicotinic acetylcholine receptors in growth factor-deprived differentiated PC-12 cells. J. Pharmacol. Exp. Ther. 307 (2003) 670-675
26. Li X.D., Arias E., Jonnala R.R., Mruthinti S., and Buccafusco J.J. Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo. J. Mol. Neurosci. 27 (2005) 325-336
27. Marin P., Maus M., Desagher S., Glowinski J., and Premont J. Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuroreport 5 (1994) 1977-1980
28. Meyer E.M., Tay E.T., Papke R.L., Meyers C., Huang G.L., and de Fiebre C.M. 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Res. 768 (1997) 49-56
29. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., and Arendash G.W. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408 (2000) 982-985
30. Papke R.L., Bencherif M., and Lippiello P. An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype. Neurosci. Lett. 213 (1996) 201-204
31. Paule M.G., Bushnell P.J., Maurissen J.P., Wenger G.R., Buccafusco J.J., Chelonis J.J., and Elliott R. Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans. Neurotoxicol. Teratol. 20 (1998) 493-502
32. Prendergast M.A., Jackson W.J., Terry Jr. A.V., Kille N.J., Arneric S.P., Decker M.W., and Buccafusco J.J. Age-related differences in distractibility and response to methylphenidate in monkeys. Cereb. Cortex. 8 (1998) 164-172
33. Ren K., Puig V., Papke R.L., Itoh Y., Hughes J.A., and Meyer E.M. Multiple calcium channels and kinases mediate alpha7 nicotinic receptor neuroprotection in PC12 cells. J. Neurochem. 94 (2005) 926-933
34. Sani S., Traul D., Klink A., Niaraki N., Gonzalo-Ruiz A., Wu C.K., and Geula C. Distribution, progression and chemical composition of cortical amyloid-beta deposits in aged rhesus monkeys: similarities to the human. Acta Neuropathol. (Ber.). 105 (2003) 145-156
35. Savonenko A., Xu G.M., Melnikova T., Morton J.L., Gonzales V., Wong M.P., Price D.L., Tang F., Markowska A.L., and Borchelt D.R. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol. Dis. 18 (2005) 602-617
36. Schenk D., Hagen M., and Seubert P. Current progress in beta-amyloid immunotherapy. Curr. Opin. Immunol. 16 (2004) 599-606
37. Summers J.B., Prendergast M.A., Hill W.D., and Buccafusco J.J. Localization of ubiquitin in the plaques of five aged primates by dual-label fluroescent immunhistochemistry. Alzheimer's Res. 3 (1997) 11-21
38. Terry Jr. A.V., Jackson W.J., and Buccafusco J.J. Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by young and aged monkeys. Cereb. Cortex 3 (1993) 304-312
39. Terry Jr. A.V., Buccafusco J.J., Borsini F., and Leusch A. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine. Psychopharmacology (Berl). 162 (2002) 292-300
40. Terry Jr. A.V., Risbrough V.B., Buccafusco J.J., and Menzaghi F. Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys. J. Pharmacol. Exp. Ther. 301 (2002) 284-292
41. Ting J.T., Kelley B.G., Lambert T.J., Cook D.G., and Sullivan J.M. Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 353-358
42. Weber B., Schaper C., Scholz J., Bein B., Rodde C.H., and Tonner P. Interaction of the amyloid precursor like protein 1 with the alpha2A-adrenergic receptor increases agonist-mediated inhibition of adenylate cyclase. Cell. Signal 18 (2006) 1748-1757
43. White D.A., and Murphy C.F. Working memory for nonverbal auditory information in dementia of the Alzheimer type. Arch. Clin. Neuropsychol. 13 (1998) 339-347
44. Youdim M.B., and Buccafusco J.J. CNS Targets for multi-functional drugs in the treatment of Alzheimer's and Parkinson's diseases. J. Neural Transm. 112 (2005) 519-537
45. Zamani M.R., Allen Y.S., Owen G.P., and Gray J.A. Nicotine modulates the neurotoxic effect of beta-amyloid protein(25-35) in hippocampal cultures. Neuroreport 8 (1997) 513-517